KRAS - human gene knockout kit via CRISPR, HDR mediated
| Format | 2 gRNA vectors, 1 Luciferase-Puro donor, 1 scramble control |
| Donor DNA | Luciferase-Puro |
Products
Kras - mouse gene knockout kit via CRISPR, HDR mediated
| Format | 2 gRNA vectors, 1 GFP-puro donor, 1 scramble control |
| Donor DNA | GFP-puro |
Kras - mouse gene knockout kit via CRISPR, HDR mediated
| Format | 2 gRNA vectors, 1 RFP-BSD donor, 1 scramble control |
| Donor DNA | RFP-BSD |
Kras CRISPRa kit - CRISPR gene activation of mouse Kirsten rat sarcoma viral oncogene homolog
| Format | 3 gRNAs (5ug each), 1 scramble ctrl (10ug) and 1 enhancer vector (10ug) |
KRAS CRISPRa kit - CRISPR gene activation of human KRAS proto-oncogene, GTPase
| Format | 3 gRNAs (5ug each), 1 scramble ctrl (10ug) and 1 enhancer vector (10ug) |
KRAS - human gene knockout kit via CRISPR, HDR mediated
| Format | 2 gRNA vectors, 1 mBFP-Neo donor, 1 scramble control |
| Donor DNA | mBFP-Neo |
KRAS - human gene knockout kit via CRISPR, HDR mediated
| Format | 2 gRNA vectors, 1 RFP-BSD donor, 1 scramble control |
| Donor DNA | RFP-BSD |
Kras - mouse gene knockout kit via CRISPR, HDR mediated
| Format | 2 gRNA vectors, 1 mBFP-Neo donor, 1 scramble control |
| Donor DNA | mBFP-Neo |
Kras - mouse gene knockout kit via CRISPR, HDR mediated
| Format | 2 gRNA vectors, 1 Luciferase-Puro donor, 1 scramble control |
| Donor DNA | Luciferase-Puro |
qSTAR qPCR primer pairs against Homo sapiens gene KRAS
qSTAR qPCR primer pairs against Mus musculus gene Kras
KRAS - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector, 5µg of each construct provided
| Format | Lentiviral plasmids |
| Vector | pGFP-C-shLenti |
qPCR primer pairs and template standards against Mus musculus gene Kras
| Application | Plasmid of exact quantity for transcript copy number calculation |
qPCR primer pairs and template standards against Homo sapiens gene KRAS
| Application | Plasmid of exact quantity for transcript copy number calculation |
Kras (Rat) - 3 unique 27mer siRNA duplexes - 2 nmol each
| Purity | HPLC purified |
| Number of Transfections | Approximately 330 transfections/2nmol in 24-well plate under optimized conditions (final conc. 10 nM). |
活动过滤器
优化搜索结果
Species
Reactivities
Antibody Hosts
Expression Hosts
Lentivirus
Vectors
- pCMV6-Entry (26)
- pLenti-C-Myc-DDK-P2A-Puro (4)
- pLenti-C-mGFP-P2A-Puro (4)
- pCMV6-AC-GFP (3)
- pGFP-C-shLenti (3)
- pLenti-C-Myc-DDK (3)
- pLenti-C-mGFP (3)
- pRS (3)
- EF1a-GFP-P2A-Puro (2)
- GFP-puro (2)
- Luciferase-Puro (2)
- RFP-BSD (2)
- mBFP-Neo (2)
- pRFP-C-RS (2)
- PCMV6-Kan/Neo (1)
- pCMV6-XL4 (1)
- pCMV6-XL6 (1)
- pGFP-V-RS (1)
Reporters
Knockout (KO) Validation
Conjugates
Modifications
Isotypes
Clonalities
Assay Types
Brands
QC Levels
Families
Pathways
- Acute myeloid leukemia (98)
- Axon guidance (98)
- B cell receptor signaling pathway (98)
- Bladder cancer (98)
- Chemokine signaling pathway (98)
- Chronic myeloid leukemia (98)
- Colorectal cancer (98)
- Dorso-ventral axis formation (98)
- Endometrial cancer (98)
- ErbB signaling pathway (98)
- Fc epsilon RI signaling pathway (98)
- Gap junction (98)
- Glioma (98)
- GnRH signaling pathway (98)
- Insulin signaling pathway (98)
- Long-term depression (98)
- Long-term potentiation (98)
- MAPK signaling pathway (98)
- Melanogenesis (98)
- Melanoma (98)
- Natural killer cell mediated cytotoxicity (98)
- Neurotrophin signaling pathway (98)
- Non-small cell lung cancer (98)
- Pancreatic cancer (98)
- Pathways in cancer (98)
- Progesterone-mediated oocyte maturation (98)
- Prostate cancer (98)
- Regulation of actin cytoskeleton (98)
- Renal cell carcinoma (98)
- T cell receptor signaling pathway (98)
- Thyroid cancer (98)
- Tight junction (98)
- VEGF signaling pathway (98)
